SDK invests in BIAsep to get resins know-how
Showa Denko KK (SDK) wants a share of the of the biopharmaceutical resins sector and has partnered with purification tech firm BIA Separations (BIASep) to get it.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs